Article
Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells
8 May 2024
Abstract excerpt
BACKGROUND: Circulating tumor cells (CTCs) hold immense promise for unraveling tumor heterogeneity and understanding treatment resistance. However, conventional methods, especially in cancers like non-small cell lung cancer (NSCLC), often yield low CTC numbers, hindering comprehensive analyses. This study addresses this limitation by employing diagnostic leukapheresis (DLA) to cancer patients, enabling the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
